East Asia Emerging as Clinical Trials Hub for Pharma, Biotech
BEIJING – Asia is rapidly becoming the location of choice for clinical studies by many leading drug developers, with the number of studies in East Asia already topping 14,000, and Mainland China, Hong Kong, South Korea and Taiwan emerging as popular locations.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST